← Open Payments lookup

ERICA KOEHLER-SCHMIDT: Open Payments

NPI 1508590217 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,144 in 127 payments from 20 companies in 2025. Trend: 2023 $1,452 · 2024 $1,585 · 2025 $2,144

Food & beverage: $2,144
CompanyPaymentsAmount
ABBVIE INC.32$470
Lundbeck LLC23$389
Otsuka America Pharmaceutical, Inc.14$245
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$229
Teva Pharmaceuticals USA, Inc.13$148
Axsome Therapeutics, Inc.5$101
Alkermes, Inc.4$73
Biogen, Inc.3$70
Neos Therapeutics, LP4$69
Supernus Pharmaceuticals, Inc.3$62

Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA, ZURZUVAE, Sunosi.

Industry payments across NE — which companies pay providers there.